| Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
---|
Net income (loss) | 33 | 120 | 142 | 127 | 208 | 136 | 218 | 423 | 169 |
---|
Bad debt expense (benefit) | 1 | 1 | -0 | 3 | 1 | 2 | 3 | 2 | 3 |
---|
Depreciation and amortization | 2 | 3 | 3 | 4 | 5 | 5 | 5 | 7 | 8 |
---|
Equity-based compensation | 120 | 46 | 77 | 96 | 123 | 124 | 134 | 168 | 129 |
---|
Deferred tax provision | -1 | 1 | -1 | 192 | 7 | 4 | 39 | 23 | 27 |
---|
Gain on equity method investment | - | - | - | - | - | - | - | 30 | 3 |
---|
Other | -3 | -1 | -2 | -7 | -3 | 7 | 2 | 6 | -12 |
---|
Accounts receivable | -5 | 8 | -6 | 36 | -1 | -7 | 47 | -27 | 20 |
---|
Accrued and other receivables | - | - | - | - | 6 | -4 | 1 | 15 | -22 |
---|
Prepaid expenses and other assets | -2 | 5 | -2 | 5 | 1 | 2 | -1 | 3 | 15 |
---|
Deferred compensation | 2 | 3 | -0 | 0 | -0 | 3 | 0 | -1 | 4 |
---|
Compensation payable | 34 | -11 | 11 | 12 | 53 | -35 | 57 | 283 | -255 |
---|
Accounts payable, accrued expenses and other liabilities | - | - | - | - | - | -3 | 21 | 53 | -45 |
---|
Deferred revenue | - | - | - | - | 2 | -4 | -0 | 2 | 3 |
---|
Dividends received | - | 4 | 1 | 12 | 3 | 3 | 2 | 3 | 3 |
---|
Net cash provided by (used in) operating activities | - | - | - | 233 | 391 | 209 | 429 | 937 | 33 |
---|
Purchases of investments | 131 | 158 | 121 | 180 | 184 | 212 | 391 | 486 | 335 |
---|
Proceeds from sales of investments | 157 | 160 | 126 | 116 | 200 | 120 | 391 | 456 | 333 |
---|
Note payments received from (issued to) employees | - | - | - | - | - | - | - | 0 | -3 |
---|
Purchases of equipment and leasehold improvements | 4 | 4 | 3 | 6 | 7 | 6 | 41 | 16 | 6 |
---|
Proceeds from partial sale of equity method investment | - | 0 | 0 | - | - | 47 | - | 29 | - |
---|
Net cash provided by (used in) investing activities | - | - | - | -69 | 9 | -52 | -40 | -17 | -11 |
---|
Payments for dividends and tax distributions | 76 | 81 | 155 | 256 | 314 | 209 | 283 | 480 | 175 |
---|
Payments for treasury stock purchases | - | - | - | - | - | - | - | 104 | 148 |
---|
Payments under tax receivable agreement | - | 2 | - | 10 | 11 | 14 | 36 | 19 | 7 |
---|
Proceeds from Stock Options Exercised | - | - | - | 6 | 7 | 21 | 12 | - | - |
---|
Other proceeds | -1 | - | - | - | - | - | - | 0 | 2 |
---|
Net cash provided by (used in) financing activities | - | - | - | -273 | -352 | -253 | -352 | -603 | -327 |
---|
Effect of exchange rate fluctuations on cash, cash equivalents, and restricted cash | - | - | - | - | -1 | 2 | -3 | 0 | -8 |
---|
Net increase (decrease) in cash, cash equivalents, and restricted cash | - | - | - | - | 48 | -93 | 35 | 318 | -313 |
---|
Income taxes, net | - | - | - | 32 | 23 | 13 | -0 | 55 | 76 |
---|
Conversion of Stock, Amount Converted | - | 5 | 1 | 56 | 31 | 1 | 15 | 27 | 7 |
---|
Dividends in kind | - | 4 | 23 | 25 | 50 | 33 | 41 | 63 | 21 |
---|
Non-cash settlement of accounts receivable | - | - | - | - | - | - | - | 19 | 11 |
---|
Settlement of partnership units not yet paid | - | - | - | - | - | - | - | 0 | - |
---|
Forfeiture of fully-vested Group LP units or other equity units | - | 1 | 0 | 0 | 1 | 2 | 0 | 0 | - |
---|